Nationwide Recall of Heparin Sodium USP
Hundreds of reports of serious injuries and/or deaths have been filed with the U.S. Food and Drug Administration (FDA) by patients who have used the drug Heparin and their doctors. Baxter Healthcare Corp., a subsidiary of Deerfield, Ill.-based Baxter International Inc., began recalling its Heparin products in January 2008. In March 2008, Bethlehem, Penn.-based B. Braun Medical Inc. announced a nationwide recall of products containing Heparin Sodium USP based on public health concerns.
Heparin Recall Details
The March 2008 Heparin recall was put in place after B. Braun Medical disclosed that company supplier Scientific Protein Laboratories revealed that one lot of Heparin Sodium, USP Active Pharmaceutical Ingredient contained a Heparin-like contaminant. Users of any of the recalled Heparin products are warned to discontinue use immediately. Patients who may be suffering any problems related to the use of Heparin Sodium USP should contact their doctor.
Adverse Reactions to Heparin
Adverse reactions to Heparin include low blood pressure, shortness of breath, nausea, vomiting, diarrhea, abdominal pain, chest pain, increased heart rate, dizziness, fainting, unresponsiveness, drug ineffectiveness, burning sensations, redness or paleness of skin, abnormal skin sensations, and headache. The manufacturer has admitted that some of the adverse reactions may be severe or life-threatening.
If you or a love one has used Heparin and are suffering any adverse side effects, please contact our office for a free evaluation.
Visit the FDA website for more details and the list of recalled Heparin Sodium USP Finished Product lots.
